Furthermore, we show that in the presence of PAPR inhibitor, inducing the degradation of IKZF1 by inhibiting USP7 or activating CRBN results in a synthetic lethal effect in MM cells in vitro and in vivo. The gene discussed is USP7; the disease is Miyoshi myopathy.